English
简体中文
Total: £ 56.28
Published Date: 2024-07-18 | Pages: 87 | Tables: 201 | Pharma & Healthcare
The global Menopause Hormonal Drug market was valued at US$ 13210 million in 2023 and is anticipated to reach US$ 18930 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Menopause Hormonal Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menopause Hormonal Drug.
Report Scope
The Menopause Hormonal Drug market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Menopause Hormonal Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menopause Hormonal Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Novartis
Novo Nordisk
Pfizer
Allergan
Emcure Pharmaceuticals
Eli Lilly And Company
Bayer
Theramex
AbbVie
Segment by Type
Table
Gel
Spray
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Menopause Hormonal Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Menopause Hormonal Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Menopause Hormonal Drug Market Overview
1.1 Product Overview and Scope of Menopause Hormonal Drug
1.2 Menopause Hormonal Drug Segment by Type
1.2.1 Global Menopause Hormonal Drug Market Value Comparison by Type (2024-2030)
1.2.2 Table
1.2.3 Gel
1.2.4 Spray
1.2.5 Others
1.3 Menopause Hormonal Drug Segment by Application
1.3.1 Global Menopause Hormonal Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Menopause Hormonal Drug Market Size Estimates and Forecasts
1.4.1 Global Menopause Hormonal Drug Revenue 2019-2030
1.4.2 Global Menopause Hormonal Drug Sales 2019-2030
1.4.3 Global Menopause Hormonal Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Menopause Hormonal Drug Market Competition by Manufacturers
2.1 Global Menopause Hormonal Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Menopause Hormonal Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Menopause Hormonal Drug Average Price by Manufacturers (2019-2024)
2.4 Global Menopause Hormonal Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Menopause Hormonal Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Menopause Hormonal Drug, Product Type & Application
2.7 Menopause Hormonal Drug Market Competitive Situation and Trends
2.7.1 Menopause Hormonal Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Menopause Hormonal Drug Players Market Share by Revenue
2.7.3 Global Menopause Hormonal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Menopause Hormonal Drug Retrospective Market Scenario by Region
3.1 Global Menopause Hormonal Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Menopause Hormonal Drug Global Menopause Hormonal Drug Sales by Region: 2019-2030
3.2.1 Global Menopause Hormonal Drug Sales by Region: 2019-2024
3.2.2 Global Menopause Hormonal Drug Sales by Region: 2025-2030
3.3 Global Menopause Hormonal Drug Global Menopause Hormonal Drug Revenue by Region: 2019-2030
3.3.1 Global Menopause Hormonal Drug Revenue by Region: 2019-2024
3.3.2 Global Menopause Hormonal Drug Revenue by Region: 2025-2030
3.4 North America Menopause Hormonal Drug Market Facts & Figures by Country
3.4.1 North America Menopause Hormonal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Menopause Hormonal Drug Sales by Country (2019-2030)
3.4.3 North America Menopause Hormonal Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Menopause Hormonal Drug Market Facts & Figures by Country
3.5.1 Europe Menopause Hormonal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Menopause Hormonal Drug Sales by Country (2019-2030)
3.5.3 Europe Menopause Hormonal Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Menopause Hormonal Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Menopause Hormonal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Menopause Hormonal Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Menopause Hormonal Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Menopause Hormonal Drug Market Facts & Figures by Country
3.7.1 Latin America Menopause Hormonal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Menopause Hormonal Drug Sales by Country (2019-2030)
3.7.3 Latin America Menopause Hormonal Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Menopause Hormonal Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Menopause Hormonal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Menopause Hormonal Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Menopause Hormonal Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Menopause Hormonal Drug Sales by Type (2019-2030)
4.1.1 Global Menopause Hormonal Drug Sales by Type (2019-2024)
4.1.2 Global Menopause Hormonal Drug Sales by Type (2025-2030)
4.1.3 Global Menopause Hormonal Drug Sales Market Share by Type (2019-2030)
4.2 Global Menopause Hormonal Drug Revenue by Type (2019-2030)
4.2.1 Global Menopause Hormonal Drug Revenue by Type (2019-2024)
4.2.2 Global Menopause Hormonal Drug Revenue by Type (2025-2030)
4.2.3 Global Menopause Hormonal Drug Revenue Market Share by Type (2019-2030)
4.3 Global Menopause Hormonal Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Menopause Hormonal Drug Sales by Application (2019-2030)
5.1.1 Global Menopause Hormonal Drug Sales by Application (2019-2024)
5.1.2 Global Menopause Hormonal Drug Sales by Application (2025-2030)
5.1.3 Global Menopause Hormonal Drug Sales Market Share by Application (2019-2030)
5.2 Global Menopause Hormonal Drug Revenue by Application (2019-2030)
5.2.1 Global Menopause Hormonal Drug Revenue by Application (2019-2024)
5.2.2 Global Menopause Hormonal Drug Revenue by Application (2025-2030)
5.2.3 Global Menopause Hormonal Drug Revenue Market Share by Application (2019-2030)
5.3 Global Menopause Hormonal Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Menopause Hormonal Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Menopause Hormonal Drug Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Corporation Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novo Nordisk Menopause Hormonal Drug Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Menopause Hormonal Drug Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Corporation Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Allergan Menopause Hormonal Drug Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 Emcure Pharmaceuticals
6.6.1 Emcure Pharmaceuticals Corporation Information
6.6.2 Emcure Pharmaceuticals Description and Business Overview
6.6.3 Emcure Pharmaceuticals Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Emcure Pharmaceuticals Menopause Hormonal Drug Product Portfolio
6.6.5 Emcure Pharmaceuticals Recent Developments/Updates
6.7 Eli Lilly And Company
6.6.1 Eli Lilly And Company Corporation Information
6.6.2 Eli Lilly And Company Description and Business Overview
6.6.3 Eli Lilly And Company Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly And Company Menopause Hormonal Drug Product Portfolio
6.7.5 Eli Lilly And Company Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Menopause Hormonal Drug Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Theramex
6.9.1 Theramex Corporation Information
6.9.2 Theramex Description and Business Overview
6.9.3 Theramex Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Theramex Menopause Hormonal Drug Product Portfolio
6.9.5 Theramex Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Corporation Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Menopause Hormonal Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AbbVie Menopause Hormonal Drug Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Menopause Hormonal Drug Industry Chain Analysis
7.2 Menopause Hormonal Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Menopause Hormonal Drug Production Mode & Process
7.4 Menopause Hormonal Drug Sales and Marketing
7.4.1 Menopause Hormonal Drug Sales Channels
7.4.2 Menopause Hormonal Drug Distributors
7.5 Menopause Hormonal Drug Customers
8 Menopause Hormonal Drug Market Dynamics
8.1 Menopause Hormonal Drug Industry Trends
8.2 Menopause Hormonal Drug Market Drivers
8.3 Menopause Hormonal Drug Market Challenges
8.4 Menopause Hormonal Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Menopause Hormonal Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Menopause Hormonal Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Menopause Hormonal Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Menopause Hormonal Drug Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Menopause Hormonal Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Menopause Hormonal Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Menopause Hormonal Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Menopause Hormonal Drug Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Menopause Hormonal Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Menopause Hormonal Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Menopause Hormonal Drug, Product Type & Application
Table 12. Global Key Manufacturers of Menopause Hormonal Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Menopause Hormonal Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopause Hormonal Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Menopause Hormonal Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Menopause Hormonal Drug Sales by Region (2019-2024) & (Tons)
Table 18. Global Menopause Hormonal Drug Sales Market Share by Region (2019-2024)
Table 19. Global Menopause Hormonal Drug Sales by Region (2025-2030) & (Tons)
Table 20. Global Menopause Hormonal Drug Sales Market Share by Region (2025-2030)
Table 21. Global Menopause Hormonal Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Menopause Hormonal Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Menopause Hormonal Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Menopause Hormonal Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Menopause Hormonal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Menopause Hormonal Drug Sales by Country (2019-2024) & (Tons)
Table 27. North America Menopause Hormonal Drug Sales by Country (2025-2030) & (Tons)
Table 28. North America Menopause Hormonal Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Menopause Hormonal Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Menopause Hormonal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Menopause Hormonal Drug Sales by Country (2019-2024) & (Tons)
Table 32. Europe Menopause Hormonal Drug Sales by Country (2025-2030) & (Tons)
Table 33. Europe Menopause Hormonal Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Menopause Hormonal Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Menopause Hormonal Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Menopause Hormonal Drug Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Menopause Hormonal Drug Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Menopause Hormonal Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Menopause Hormonal Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Menopause Hormonal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Menopause Hormonal Drug Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Menopause Hormonal Drug Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Menopause Hormonal Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Menopause Hormonal Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Menopause Hormonal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Menopause Hormonal Drug Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Menopause Hormonal Drug Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Menopause Hormonal Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Menopause Hormonal Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Menopause Hormonal Drug Sales (Tons) by Type (2019-2024)
Table 51. Global Menopause Hormonal Drug Sales (Tons) by Type (2025-2030)
Table 52. Global Menopause Hormonal Drug Sales Market Share by Type (2019-2024)
Table 53. Global Menopause Hormonal Drug Sales Market Share by Type (2025-2030)
Table 54. Global Menopause Hormonal Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Menopause Hormonal Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Menopause Hormonal Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Menopause Hormonal Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Menopause Hormonal Drug Price (US$/Ton) by Type (2019-2024)
Table 59. Global Menopause Hormonal Drug Price (US$/Ton) by Type (2025-2030)
Table 60. Global Menopause Hormonal Drug Sales (Tons) by Application (2019-2024)
Table 61. Global Menopause Hormonal Drug Sales (Tons) by Application (2025-2030)
Table 62. Global Menopause Hormonal Drug Sales Market Share by Application (2019-2024)
Table 63. Global Menopause Hormonal Drug Sales Market Share by Application (2025-2030)
Table 64. Global Menopause Hormonal Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Menopause Hormonal Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Menopause Hormonal Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Menopause Hormonal Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Menopause Hormonal Drug Price (US$/Ton) by Application (2019-2024)
Table 69. Global Menopause Hormonal Drug Price (US$/Ton) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Merck Menopause Hormonal Drug Product
Table 74. Merck Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Novartis Menopause Hormonal Drug Product
Table 79. Novartis Recent Developments/Updates
Table 80. Novo Nordisk Corporation Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Novo Nordisk Menopause Hormonal Drug Product
Table 84. Novo Nordisk Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Pfizer Menopause Hormonal Drug Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Allergan Corporation Information
Table 91. Allergan Description and Business Overview
Table 92. Allergan Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Allergan Menopause Hormonal Drug Product
Table 94. Allergan Recent Developments/Updates
Table 95. Emcure Pharmaceuticals Corporation Information
Table 96. Emcure Pharmaceuticals Description and Business Overview
Table 97. Emcure Pharmaceuticals Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Emcure Pharmaceuticals Menopause Hormonal Drug Product
Table 99. Emcure Pharmaceuticals Recent Developments/Updates
Table 100. Eli Lilly And Company Corporation Information
Table 101. Eli Lilly And Company Description and Business Overview
Table 102. Eli Lilly And Company Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Eli Lilly And Company Menopause Hormonal Drug Product
Table 104. Eli Lilly And Company Recent Developments/Updates
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Bayer Menopause Hormonal Drug Product
Table 109. Bayer Recent Developments/Updates
Table 110. Theramex Corporation Information
Table 111. Theramex Description and Business Overview
Table 112. Theramex Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Theramex Menopause Hormonal Drug Product
Table 114. Theramex Recent Developments/Updates
Table 115. AbbVie Corporation Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. AbbVie Menopause Hormonal Drug Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Menopause Hormonal Drug Distributors List
Table 123. Menopause Hormonal Drug Customers List
Table 124. Menopause Hormonal Drug Market Trends
Table 125. Menopause Hormonal Drug Market Drivers
Table 126. Menopause Hormonal Drug Market Challenges
Table 127. Menopause Hormonal Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Menopause Hormonal Drug
Figure 2. Global Menopause Hormonal Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Menopause Hormonal Drug Market Share by Type in 2023 & 2030
Figure 4. Table Product Picture
Figure 5. Gel Product Picture
Figure 6. Spray Product Picture
Figure 7. Others Product Picture
Figure 8. Global Menopause Hormonal Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Menopause Hormonal Drug Market Share by Application in 2023 & 2030
Figure 10. Hospital Pharmacies
Figure 11. Retail Pharmacies
Figure 12. Online Pharmacies
Figure 13. Global Menopause Hormonal Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Menopause Hormonal Drug Market Size (2019-2030) & (US$ Million)
Figure 15. Global Menopause Hormonal Drug Sales (2019-2030) & (Tons)
Figure 16. Global Menopause Hormonal Drug Average Price (US$/Ton) & (2019-2030)
Figure 17. Menopause Hormonal Drug Report Years Considered
Figure 18. Menopause Hormonal Drug Sales Share by Manufacturers in 2023
Figure 19. Global Menopause Hormonal Drug Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Menopause Hormonal Drug Players: Market Share by Revenue in 2023
Figure 21. Menopause Hormonal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Menopause Hormonal Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Menopause Hormonal Drug Sales Market Share by Country (2019-2030)
Figure 24. North America Menopause Hormonal Drug Revenue Market Share by Country (2019-2030)
Figure 25. United States Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Menopause Hormonal Drug Sales Market Share by Country (2019-2030)
Figure 28. Europe Menopause Hormonal Drug Revenue Market Share by Country (2019-2030)
Figure 29. Germany Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Menopause Hormonal Drug Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Menopause Hormonal Drug Revenue Market Share by Region (2019-2030)
Figure 36. China Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Menopause Hormonal Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America Menopause Hormonal Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Menopause Hormonal Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Menopause Hormonal Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Menopause Hormonal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Menopause Hormonal Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of Menopause Hormonal Drug by Type (2019-2030)
Figure 55. Global Menopause Hormonal Drug Price (US$/Ton) by Type (2019-2030)
Figure 56. Global Sales Market Share of Menopause Hormonal Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of Menopause Hormonal Drug by Application (2019-2030)
Figure 58. Global Menopause Hormonal Drug Price (US$/Ton) by Application (2019-2030)
Figure 59. Menopause Hormonal Drug Value Chain
Figure 60. Menopause Hormonal Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
